50 related articles for article (PubMed ID: 10490797)
1. Valvular regurgitation and surgery associated with fenfluramine use: an analysis of 5743 individuals.
Dahl CF; Allen MR; Urie PM; Hopkins PN
BMC Med; 2008 Nov; 6():34. PubMed ID: 18990200
[TBL] [Abstract][Full Text] [Related]
2. Re: Estimate of deaths due to valvular insufficiency attributable to the use of benfluorex in France.
Deltour N; Coste M; Tupinon-Mathieu I
Pharmacoepidemiol Drug Saf; 2012 Jun; 21(6):584-5; author reply 586-8. PubMed ID: 22517617
[No Abstract] [Full Text] [Related]
3. The proposed mechanisms of action of CBD in epilepsy.
Gray RA; Whalley BJ
Epileptic Disord; 2020 Jan; 22(S1):10-15. PubMed ID: 32053110
[TBL] [Abstract][Full Text] [Related]
4. Fenfluramine hydrochloride for the treatment of seizures in Dravet syndrome: a randomised, double-blind, placebo-controlled trial.
Lagae L; Sullivan J; Knupp K; Laux L; Polster T; Nikanorova M; Devinsky O; Cross JH; Guerrini R; Talwar D; Miller I; Farfel G; Galer BS; Gammaitoni A; Mistry A; Morrison G; Lock M; Agarwal A; Lai WW; Ceulemans B;
Lancet; 2019 Dec; 394(10216):2243-2254. PubMed ID: 31862249
[TBL] [Abstract][Full Text] [Related]
5. Reintroducing Fenfluramine as a Treatment for Seizures: Current Knowledge, Recommendations and Gaps in Understanding.
Dini G; Di Cara G; Ferrara P; Striano P; Verrotti A
Neuropsychiatr Dis Treat; 2023; 19():2013-2025. PubMed ID: 37790801
[TBL] [Abstract][Full Text] [Related]
6. Fenfluramine: A Review of Pharmacology, Clinical Efficacy, and Safety in Epilepsy.
Samanta D
Children (Basel); 2022 Aug; 9(8):. PubMed ID: 36010049
[TBL] [Abstract][Full Text] [Related]
7. Assessing the use of prescription drugs and dietary supplements in obese respondents in the National Health and Nutrition Examination Survey.
Barrett LA; Xing A; Sheffler J; Steidley E; Adam TJ; Zhang R; He Z
PLoS One; 2022; 17(6):e0269241. PubMed ID: 35657782
[TBL] [Abstract][Full Text] [Related]
8. Use of Zebrafish Models to Boost Research in Rare Genetic Diseases.
Crouzier L; Richard EM; Sourbron J; Lagae L; Maurice T; Delprat B
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948153
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular safety of fenfluramine in the treatment of Dravet syndrome: Analysis of an ongoing long-term open-label safety extension study.
Lai WW; Galer BS; Wong PC; Farfel G; Pringsheim M; Keane MG; Agarwal A
Epilepsia; 2020 Nov; 61(11):2386-2395. PubMed ID: 32809271
[TBL] [Abstract][Full Text] [Related]
10. Low-dose fenfluramine significantly reduces seizure frequency in Dravet syndrome: a prospective study of a new cohort of patients.
Schoonjans A; Paelinck BP; Marchau F; Gunning B; Gammaitoni A; Galer BS; Lagae L; Ceulemans B
Eur J Neurol; 2017 Feb; 24(2):309-314. PubMed ID: 27790834
[TBL] [Abstract][Full Text] [Related]
11. Low-dose fenfluramine in the treatment of neurologic disorders: experience in Dravet syndrome.
Schoonjans AS; Lagae L; Ceulemans B
Ther Adv Neurol Disord; 2015 Nov; 8(6):328-38. PubMed ID: 26600876
[TBL] [Abstract][Full Text] [Related]
12. Acute tryptophan depletion in accordance with body weight: influx of amino acids across the blood-brain barrier.
Dingerkus VL; Gaber TJ; Helmbold K; Bubenzer S; Eisert A; Sánchez CL; Zepf FD
J Neural Transm (Vienna); 2012 Sep; 119(9):1037-45. PubMed ID: 22622364
[TBL] [Abstract][Full Text] [Related]
13. Safety of drug therapies used for weight loss and treatment of obesity.
Ioannides-Demos LL; Proietto J; Tonkin AM; McNeil JJ
Drug Saf; 2006; 29(4):277-302. PubMed ID: 16569079
[TBL] [Abstract][Full Text] [Related]
14. The UCSD Statin Study: a randomized controlled trial assessing the impact of statins on selected noncardiac outcomes.
Golomb BA; Criqui MH; White HL; Dimsdale JE
Control Clin Trials; 2004 Apr; 25(2):178-202. PubMed ID: 15020036
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological approaches for the treatment of obesity.
Fernández-López JA; Remesar X; Foz M; Alemany M
Drugs; 2002; 62(6):915-44. PubMed ID: 11929339
[TBL] [Abstract][Full Text] [Related]
16. Dose-effect of fenfluramine use on the severity of valvular heart disease among fen-phen patients with valvulopathy.
Li R; Serdula MK; Williamson DF; Bowman BA; Graham DJ; Green L
Int J Obes Relat Metab Disord; 1999 Sep; 23(9):926-8. PubMed ID: 10490797
[TBL] [Abstract][Full Text] [Related]
17. Asymptomatic mitral and aortic valve disease is seen in half of the patients taking 'phen-fen'.
Griffen L; Anchors M
Arch Intern Med; 1998 Jan; 158(1):102. PubMed ID: 9437392
[No Abstract] [Full Text] [Related]
18. Diet drug-related cardiac valve disease: the Mayo Clinic echocardiographic laboratory experience.
Teramae CY; Connolly HM; Grogan M; Miller FA
Mayo Clin Proc; 2000 May; 75(5):456-61. PubMed ID: 10807073
[TBL] [Abstract][Full Text] [Related]
19. A dangerous duo? A combination of common diet drugs (fen-phen) may lead to heart valve disease.
Boughner DR
CMAJ; 1997 Sep; 157(6):705-6. PubMed ID: 9307558
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
